[HTML][HTML] Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease
MI Fonseca, SH Chu, AM Berci, ME Benoit… - Journal of …, 2011 - Springer
Background Complement proteins and activation products have been found associated with
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
[HTML][HTML] Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease
MI Fonseca, SH Chu, AM Berci… - Journal of …, 2011 - jneuroinflammation.biomedcentral …
Complement proteins and activation products have been found associated with
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease.
MI Fonseca, SH Chu, AM Berci, ME Benoit… - Journal of …, 2011 - europepmc.org
Background Complement proteins and activation products have been found associated with
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease
MI Fonseca, SH Chu, AM Berci… - Journal of …, 2011 - search.proquest.com
Background: Complement proteins and activation products have been found associated with
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
[PDF][PDF] Contribution of complement activation pathways to neuropathology differs among mouse models of AlzheimerLs disease
MI Fonseca, SH Chu, AM Berci, ME Benoit, DG Peters… - 2011 - researchgate.net
Background: Complement proteins and activation products have been found associated with
neuropathology in AlzheimerLs disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in AlzheimerLs disease (AD). Recently, a C5a receptor antagonist was …
Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease
MI Fonseca, SH Chu, AM Berci… - Journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Complement proteins and activation products have been found associated with
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
[PDF][PDF] Contribution of complement activation pathways to neuropathology differs among mouse models of AlzheimerLs disease
MI Fonseca, SH Chu, AM Berci, ME Benoit, DG Peters… - 2011 - Citeseer
Background: Complement proteins and activation products have been found associated with
neuropathology in AlzheimerLs disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in AlzheimerLs disease (AD). Recently, a C5a receptor antagonist was …
[PDF][PDF] Contribution of complement activation pathways to neuropathology differs among mouse models of AlzheimerLs disease
MI Fonseca, SH Chu, AM Berci, ME Benoit, DG Peters… - 2011 - academia.edu
Background: Complement proteins and activation products have been found associated with
neuropathology in AlzheimerLs disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in AlzheimerLs disease (AD). Recently, a C5a receptor antagonist was …
Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease
MI Fonseca, SH Chu, AM Berci, ME Benoit… - Journal of …, 2011 - go.gale.com
Background Complement proteins and activation products have been found associated with
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease.
MI Fonseca, SH Chu, AM Berci… - Journal of …, 2011 - search.ebscohost.com
Background: Complement proteins and activation products have been found associated with
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …